Is the Addition of Oral Biotin to PRP More Beneficial for Treating Male Pattern Hair Loss Compared to PRP Alone? A Randomized Control Trial
Keywords:
Androgenetic Alopecia, Biotin, PRPAbstract
Background: Androgenetic Alopecia (AGA) is a common and progressive condition of patterned hair loss from the scalp and affects both genders with a genetic background. The onset and speed of progression varies among patients. Multiple treatment modalities are in use for the treatment of AA namely minoxidil, finasteride, etc.; however, they are associated with some unacceptable side effects. The efficacy of oral supplements is controversial in AGA. Little data is available on the role of Biotin supplementation in AGA so this trial aimed to fill this research gap. Objective: To determine the effectiveness of oral Biotin in combination with PRP vs PRP alone in treating Androgenetic Alopecia. Methods: This is Randomized controlled trial (Trial registration number#TCTR20250506001). One hundred and Eighty patients were enrolled in the study. Group A consisting of 90 patients received four sessions of PRP,1 month apart while Group B was treated with a similar protocol of PRP in combination with oral Biotin 2500mcg once daily for 6 months. Patients were called for monthly follow and final assessments done after 6 months using the Dermatology Quality of Life Index (DLQI) and Digital photography. Results: The mean age in Groups A and B was 27.74±5.55&29.72±5.40 years respectively. The number of patients was comparable in both groups based on the Norwood Hamilton grading system. The family history was positive in 51.2 % of patients in Group A and 49.5% of patients in Group B. After 6 months of using DLQI and digital photography, compared to baseline, Patients in both groups gained significant hair regrowth but there was no intergroup difference (p value>0.05). Conclusions: It is concluded that the combination of Biotin supplements with PRP gives no additional benefits in AGA patients.References
Liu LP, Wariboko MA, Hu X, Wang ZH, Wu Q, Li YM. Factors associated with early-onset an-drogenetic alopecia: A scoping review. PLoS One. 2024;19(3):e0299212. Doi: 10.1371/journal.pone. 0299212.
Martinez-Jacobo L, Villarreal-Villarreal CD, Ortiz-López R, Ocampo-Candiani J, Rojas-Martínez A. Genetic and molecular aspects of androgenetic alopecia. Indian J Dermatol Vene-reol Leprol. 2018 May-Jun;84(3):263-268. Doi: 10.4103/ijdvl.IJDVL_ 262_17
Xu L, Liu KX, Senna MM. A practical approach to the diagnosis and management of hair loss in children and adolescents. Front Med. 2017;4:112.
Bansod S, Sharma A, Mhatre M. Androgenetic alopecia: Clinical features and trichoscopy. Clin Dermatol Rev. 2022;6(2):63–8. doi: 10.4103/cdr.cdr_1_22
Mu Z, Gao Y, Li K, Liu H, Zhang J. Androgenet-ic alopecia among hospital staff: a study of prevalence, types and a comparison with gen-eral population in a secondary hospital in Chi-na. Clin Cosmet Investig Dermatol. 2021:1387-92. Doi: 10.2147/ CCID.S333789.
Dhurat R, Sharma A, Rudnicka L, Kroumpou-zos G, Kassir M, Galadari H, et al. 5‐Alpha re-ductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, compar-ative efficacy, and safety. Dermatol Ther. 2020;33(3):e13379.
Doi: 10.1111/dth.13379.
Hasan R, Juma H, Eid FA, Alaswad HA, Ali WM, Aladraj FJ. Effects of hormones and endo-crine disorders on hair growth. Cureus. 2022;14(12): e32726. doi:10.7759/cureus.32726.
Kruk A, Dorosz A, Skoczeń A, Kulesza M, Wawrzy-nów W, Jakubowska MM, et al. Ad-verse effects of finasteride in men treated for benign prostatic hyperplasia and androgenetic alopecia: a literature review. J Educ Health Sport. 2025 ;79:58442.
Devjani S, Ezemma O, Kelley KJ, Stratton E, Senna M. Androgenetic Alopecia: Therapy Up-date. Dru-gs.2023;83(8):701-715. Doi: 10.1007/s40265-023-01880-x
Gentile P, Cole JP, Cole MA, Garcovich S, Bielli A, Scioli MG, et al . Evaluation of not-activated and activated PRP in hair loss treatment: role of growth factor and cytokine concentrations ob-tained by different collection systems. Int J Mol Sci. 2017; 18(2):408. Doi: 10.3390/ijms18020408.
Liu H, Welburn JPI. A circle of life: platelet and megakaryocyte cytoskeleton dynamics in health and disease. Open Biol. 2024;14(6):240041.
Doi: 10.1098/rsob.240041.
Kourosh AS, Mangual KP, Farah RS, Rao M, Hor-dinsky MK, Arruda S, et al. Platelet-rich plasma: advances and controversies in hair restoration and skin rejuvenation. Dermatol Surg. 2024;50(5): 446–52. doi: 10.1097/DSS.0000000000004115
Soleymani T, Lo Sicco K, Shapiro J. The Infatua-tion With Biotin Supplementation: Is There Truth Behind Its Rising Popularity? A Com-parative Analysis of Clinical Efficacy versus Social Popularity. J Drugs Dermatol. 2017;16(5):496-500.
Dedkova LM, Hecht SM. Expanding the scope of protein synthesis using modified ribosomes. J Am Chem Soc. 2019;141(16):6430–47.
Saleem F, Soos MP. Biotin deficiency. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing
Canda E, Kalkan Uçar S, Çoker M. Biotinidase deficiency: prevalence, impact and manage-ment strategies. Pediatric Health Med Ther. 2020;11:127-133. Doi: 10.2147/PHMT.S198656..
Bistas KG, Tadi P. Biotin. [Updated 2023 Jul 3]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK554493/.
Yengar L, Li J. Male and female pattern hair loss. Aust Prescr. 2025;48(3):93. DOI: 10.18773/austprescr.2025.020
Gupta S, Goyal I, Mahendra A. Quality of life asse-ssment in patients with androgenetic alo-pecia. Int J Trichology. 2019;11(4):147. Doi: 10.4103/ijt.ijt_6_19.
Manickam N, Mathapati P, Somasundaram K, Gopalan K, Ganga Vellaisamy S. Efficacy of Platelet-Rich Plasma in Males With Androge-netic Alopecia. Cureus. 2023;15(3):e36531.
Doi: 10.7759/cureus .36531
Tr P, Ts R, K SK, Prasanna H. A Comparative Study of Topical Procapil With Platelet-Rich Plasma Therapy Versus Topical Redensyl, Saw Palmetto, and Biotin With Platelet-Rich Plasma Therapy in the Treatment of Androgenetic Alo-pecia. Cureus. 2023;15(5):e38696. Doi: 10.7759/cureus.38696
Patel DP, Swink SM, Castelo-Soccio L. A review of the use of biotin for hair loss. Skin Append-age Disord. 2017;3(3):166-9. Doi: 10.1159/000462981.
Samadi A, Ketabi Y, Firooz R, Firooz A. Efficacy of intramuscular injections of biotin and dex-panthe-nol in the treatment of diffuse hair loss: A randomized, double‐blind controlled study comparing two brands. Dermatol Ther 2022;35(9):e15695.
Doi: 10.1111/dth.15695.
Sabry HH, Abd El Rahman SH, El Awady MA, Noureldine AM, Salama RA. Evaluation of se-rum level of biotin and effect of biotin replace-ment therapy in patients with telogen effluvi-um. Benha J Appl Sci. 2021 ;6(4):113-6.
Gupta N. Clinical Evaluation of Intradermal Platelet Rich Plasma Administration along with Oral Biotin Supplement for the Manage-ment of Androgenetic Alopecia in Adult Males: A Randomised Clinical Trial. J Clin Diagnostic Res. 2022 ;16(11)
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Journal of Pakistan Association of Dermatologists

This work is licensed under a Creative Commons Attribution 4.0 International License.
